Diabetes-Invoked High-Density Lipoprotein and Its Association With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
- 30 August 2016
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (11) , 1674-1679
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inflammation and type 2 diabetesDiabetes & Metabolism, 2012
- High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid ACardiovascular Research, 2012
- Nonenzymatic glycation of high‐density lipoprotein impairs its anti‐inflammatory effects in innate immunityDiabetes/Metabolism Research and Reviews, 2011
- Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-IArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic RabbitsCirculation, 2005
- Antiinflammatory Properties of HDLCirculation Research, 2004
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Impact of Antioxidants and HDL on Glycated LDL–Induced Generation of Fibrinolytic Regulators From Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based studyDiabetes Care, 1997
- Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.Journal of Clinical Investigation, 1995